Sterile water for injection (SWFI) and sodium chloride 0.9% for injection (NS) for use in compounding sterile preparations in the United States are in limited supply.
This shortage can directly impact patient care, thus the association is working with manufacturers and suppliers to get more information about when these issues might be resolved and looking into possible regulatory avenues for addressing these shortages.
In the meantime, NHIA has developed product shortage recommendations to help clinicians manage patients during this time when diluents, and small and large volume parenteral solutions may not be readily available, including a table of reconstitution alternatives for infusion medications.
Last week concluded the 2024 National Home Infusion Association Annual Conference (NHIA 2024), which brings together more than 1,600 home and alternate site infusion professionals for four days of networking, education, and exhibits.
The National Home Infusion Foundation (NHIF) announces the finalists for its Outstanding Abstract Achievement Award for 2024. The authors of the following 5 poster abstracts will present an overview of their research project and summarize their findings during a special clinical webinar and a panel of judges will select the award recipient.
NHIA submitted comments on a CMS PFS proposed rule (CMS-1784-P) that would affect Medicare classification and coverage of self-administered drugs, certain biologics and coding and billing requirements related to the use of single dose containers and drug waste.
